Showing results (291-300 of 412) with videos related to

Sort By:
Pageof 42
Annals of Neurology|November 16, 2024
Elevated Cerebrospinal Fluid Ubiquitin Carboxyl-Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion CarriersElizabeth R Dellar, Iolanda Vendrell, Benazir Amein, et al.
Muscle & Nerve|November 26, 2013
Electrical impedance myography correlates with standard measures of ALS severitySeward B Rutkove, James B Caress, Michael S Cartwright, et al.
Journal of Neurology|January 28, 2024
Mismatch between clinically defined classification of ALS stage and the burden of cerebral pathologyPedram Parnianpour, Michael Benatar, Hannah Briemberg, et al.
The Lancet. Neurology|May 23, 2024
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialMichael Benatar, Thomas Hansen, Dror Rom, et al.
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Skeletal muscle biomarkers of amyotrophic lateral sclerosis: a large-scale, multi-cohort proteomic studyOleksandr Dergai, Joanne Wuu, Magdalena Koziczak-Holbro, et al.
Annals of Neurology|September 29, 2025
Skeletal Muscle Biomarkers of Amyotrophic Lateral Sclerosis: A Large-Scale, Multi-Cohort Proteomic StudyOleksandr Dergai, Joanne Wuu, Magdalena Koziczak-Holbro, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Measuring neurofilament light in human plasma and cerebrospinal fluid: a comparison of five analytical immunoassaysUdit Sheth, Rebecca Harrison, Kyle Ferber, et al.
Clinical Chemistry and Laboratory Medicine|September 17, 2025
Measuring neurofilament light in human plasma and cerebrospinal fluid: a comparison of five analytical immunoassaysUdit Sheth, Rebecca Harrison, Kyle Ferber, et al.
Molecular Neurodegeneration|February 26, 2020
Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9ORF72 ALS/FTDNadja S Andrade, Melina Ramic, Rustam Esanov, et al.
Neurology|September 26, 2014
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosisAlex M Dickens, James R Larkin, Julian L Griffin, et al.
Pageof 42